Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms.
about
Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistanceActivity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections.In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteriaComparative antianaerobic activity of BMS 284756Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.In vitro activities of newer quinolones against bacteroides group organisms.Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patternsBactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum.In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinoloneAntianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agents.Investigation of toxin gene diversity and antimicrobial resistance of Clostridium difficile strains.Postantibiotic effects of gatifloxacin against gram-positive and -negative organisms.Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test results.Fluoroquinolone resistance in anaerobic bacteria following exposure to levofloxacin, trovafloxacin, and sparfloxacin in an in vitro pharmacodynamic modelActivities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.Time-kill studies of the antianaerobe activity of garenoxacin compared with those of nine other agents.In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.Factors influencing fluoroquinolone resistance.Antianaerobic activity of sulopenem compared to six other agents.Vitreous penetration of orally administered gatifloxacin in humans.
P2860
Q33614494-1E42F041-C986-4404-8B37-B8EBCB884CAFQ33976981-62B3A2C8-2B83-4B4A-92C8-4E8D8E04E421Q33978131-90F6B47E-DDED-4D9F-9455-5B0A56C395CCQ33981466-CD121C7D-AAFA-4F5F-8B67-6B694E2BFE28Q33982775-6A0CD0F8-5FBD-4D35-9032-9B9C905557DFQ34143059-686F32BB-FE3B-4C82-A33F-CCAD881340FAQ34721737-4B33DB57-C334-4C60-A4F0-55263615F75EQ34882995-4FBCD58B-5E97-41A7-8AFB-8F260A0DFD4FQ35127828-9E2DF4C4-3590-4F2F-A1B7-6E4D56D0DD8BQ36669525-CBDDDEBE-C2F5-487D-8836-D18AC01416D4Q39155301-3188DF57-76E9-4A47-84D8-C71E1F5EBD70Q39472095-818BC2FA-54E0-4C67-92C8-7837B8F1C4A6Q39474219-D48230DD-36DA-40DF-BDFA-27054FD52FC1Q39477854-6A8BAC92-98DC-488C-A640-02CD9903C00DQ39731800-2E96E015-1908-432D-8623-36F9D774C21BQ39732000-E800C11D-0C0C-4EAA-B4A9-854D5340E2B9Q39743439-DF1A94E5-82AB-41AB-8952-2816ED099685Q40130484-157EE474-BD98-45F2-8322-A8DA97F489DFQ42590584-53D0D670-6E4B-4B51-A886-BD25E1076315Q42914799-D7011F70-2174-4EC2-9401-857035C78C24Q43195705-ACEEB799-1A06-4FA3-8D15-40472F504364
P2860
Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Activities of gatifloxacin com ...... s against anaerobic organisms.
@ast
Activities of gatifloxacin com ...... s against anaerobic organisms.
@en
type
label
Activities of gatifloxacin com ...... s against anaerobic organisms.
@ast
Activities of gatifloxacin com ...... s against anaerobic organisms.
@en
prefLabel
Activities of gatifloxacin com ...... s against anaerobic organisms.
@ast
Activities of gatifloxacin com ...... s against anaerobic organisms.
@en
P2093
P2860
P1476
Activities of gatifloxacin com ...... s against anaerobic organisms.
@en
P2093
M R Jacobs
P C Appelbaum
P2860
P304
P407
P577
1998-09-01T00:00:00Z